Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass., Sept. 22, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to…
– Cantor Fitzgerald Virtual Global Healthcare Conference: September 30 – – The Cell & Gene Meeting on the Mesa Annual Conference:…
Continuous glucose monitoring reveals undertreated hypoglycemia in patients with congenital hyperinsulinism RZ358, a monoclonal antibody in Phase 2b development, has…
ELI-005, containing the Amphiphile vaccine adjuvant AMP-CpG, induced >25-fold higher antigen-specific T cells in the peripheral blood and exhibited potent…
Nine Towers Completed with a value of $620,000VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — TOWER ONE WIRELESS CORP.…
ERYTECH Announces the Availabilityof its Half-Year Financial Report 2021 Lyon (France) and Cambridge, MA (U.S.), Septembre 22, 2021 – ERYTECH…
PRESS RELEASE AB SCIENCE RECEIVES HEALTH CANADA APPROVAL LETTER TO COMMENCE PHASE I/II TRIAL OF AB8939 IN THE TREATMENT OF…
BOSTON, Sept. 21, 2021 (GLOBE NEWSWIRE) — In a release issued on Wednesday, September 21 by Rhythm Pharmaceuticals, Inc. (Nasdaq:…
– IMCIVREE is indicated for treatment of obesity and control of hunger associated with genetically confirmed loss-of-function biallelic pro-opiomelanocortin (POMC),…
TORONTO and CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) announced…